 |
 |
| Anatomy | Abstracting, Coding, & Staging | Treat. | Exercise || Go to Cervical Cancer || | |||||||||
|
|||||||||||
| Introduction to Uterine Cancer | Risk Factors | Signs & Symptoms | | Unit Review & Quiz | | |||||||||||
|
|
| Anatomy | Abstracting, Coding, & Staging | Treat. | Exercise || Go to Cervical Cancer || | |||||||||
|
|||||||||||
| Introduction to Uterine Cancer | Risk Factors | Signs & Symptoms | | Unit Review & Quiz | | |||||||||||
(from the National Cancer Institute's Physician Data Query system, July 2002)
Prognostic factors include grade of tumor, depth of myometrial invasion, and histology. High estrogen receptor levels have a favorable impact on prognosis.
| Stage 0 | 100% |
| Stage I | 70-95% |
| Stage II | up to 55% |
| Stage III | up to 25% |
| Stage IV | up to 5% |
Hydatidiform mole 100% (if treated properly).
